FDA.reportPublic FDA data

Calypxo Pain Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Calypxo Pain Relief
Generic name
METHYL SALICYLATE, MENTHOL
Manufacturer
Asclemed USA, Inc
Product type
HUMAN OTC DRUG
SPL set ID
bd9d0bc0-5705-4c73-bcd6-f6cdb68e05b6
SPL ID
07cec8ef-ecc9-ac49-e063-6294a90a6083
Version
6
Effective date
2023-10-16
Source export date
2026-08-01
Source partition
14
Source file
https://download.open.fda.gov/drug/label/drug-label-0014-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-08-01/a02fd54f2831abedf72de26b709069bc80ecbb9303a4823ffe5695ea1bb3d85a/drug-label-0014-of-0014.json.zip
Source manifest SHA-256
bdd1454d0606b622b70458a306b8a10d8a8787db06fd9f46e69c7f7a4524b630
Import run
20260801T225920Z
Imported at
2026-08-01 23:40:04
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning For external use only. Avoid contact with eyes and mucous membranes. Do not bandage tightly or cover treated areas. Do not use with heating pad. Do not apply to open wounds or damages skin. A mild burning sensation may occur. If severe burning sensation occurs, discontinue use immediately. If symptoms persist for more than seven days, discontinue use and consult physician. Keep out of reach of children. If swallowed, consult physician. If pregnant or breast feeding, contact physician prior to use.